Engie's nuclear EBIT halves to €111m as Belgian reactors leave the merchant book — bearish for captured-price upside, neutral for TTF

Engie's nuclear EBIT halves to €111m as Belgian reactors leave the merchant book — bearish for captured-price upside, neutral for TTF Engie's Q1 2026 print confirms the structural shift traders have been pricing: nuclear EBIT collapsed to €111m from €406m a year earlier, a €295m drop driven by the Belgian nuclear phase-out and lower French power prices. The headline takeaway is that Belgian nuclear volumes are no longer merchant. Following the 10-year extension deal for Tihange 3 and Doel 4, from 2026 the only hedged outright nuclear volume Engie reports is French production — removing a chunk of captured-price optionality that used to flex with forward power. For anyone trading Belgian baseload or watching Engie as a proxy for Northwest European nuclear length, the merchant signal from this book is now materially smaller. Group EBIT ex-Nuclear came in at €3.4bn, down 8% gross and 7% organic against a high Q1 2025 base of €3.7bn. Management framed the €237m organic decline as "expected market normalization" — read: the legacy crisis-era margins are unwinding. Gas Generation is where that bites hardest: EBIT fell to €237m from €431m (−€194m gross, −€140m organic), on lower captured spreads in Europe, Middle East disposals, a Peru one-off, and the gradual exit from coal-fired generation in Chile. Lower European power prices are the through-line across Renewable & BESS (€730m, with European power weakness cited) and Gas Generation alike — consistent with the soft front-of-curve baseload complex rather than any Engie-specific miss. Supply & Energy Management dropped to €1,141m from €1,299m, −€172m organic in B2B as legacy contracts signed under favorable conditions roll off and the positive timing effect versus Q1 2025 fades. Energy Management itself held at €288m, helped by a positive one-off on a gas-contract settlement — a reminder the LNG/gas portfolio is still throwing off settlement gains even as spot volatility compresses. Engie flagged the "lowest power price sensitivity ever," with renewables and nuclear paired against flexible gas procurement and limited merchant exposure. That de-risks earnings but caps the upside if European power rallies. Networks remain the ballast: €1,261m EBIT, up €9m organic on tariff increases and new regulated assets, with UKPN closing in May 2026 set to add €0.9–1.1bn FY26 contribution. The capital story is clean — Economic Net Debt fell €4.0bn to €41.2bn including a €3.0bn capital increase (107m shares at €28), Economic Net Debt/EBITDA improved to 2.9x, and 'Strong investment grade' was held. Average cost of gross debt sits at 4.0%; the April hybrid issuance priced at 4.375%–6.125%. Full-year guidance was confirmed across the board: NRIgs €4.6–5.2bn, EBITDA €13.8–14.8bn, on commodity forward prices as of 31 March 2026 and average weather. Crucially, the Belgian State nuclear transfer talks aim to conclude heads of terms by 1 October 2026, with ongoing dismantling work suspended across five reactors and "no net impact on Group's financial position." That removes a long-dated provisioning overhang but transfers any future Belgian nuclear merchant upside to the State. Net read: bearish for European captured power margins through 2026, confirming normalization is real and not weather noise; neutral-to-supportive for TTF and JKM, since Engie's gas length is now procurement-hedged with settlement gains rather than directional. The 1 Oct nuclear milestone is the binary event. What to Watch - 1 October 2026 heads-of-terms deadline on the Belgian nuclear transfer — slippage reopens the provisioning question. - French captured nuclear price vs forward French baseload — the only merchant nuclear signal left in the book. - European clean spark spreads into summer — Gas Generation's €237m run-rate is exposed if captured spreads compress further. - UKPN May close and its €0.9–1.1bn FY26 contribution landing as guided. - Any further B2B legacy-contract unwind beyond the €172m organic Q1 drag.